Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Petri is a Boston-based venture firm and startup accelerator focused on formation-stage companies at the intersection of biology and engineering. Rather than developing its own therapeutic pipeline, Petri provides pre-seed and seed capital, mentorship, talent recruiting, intellectual property support, lab access, and company-building resources to founders creating new biotech and bioengineering businesses. Its portfolio spans human health, therapeutics, tools, food, agriculture, biomaterials, and sustainability. The organization was launched with support from Pillar VC and a network of prominent biotech entrepreneurs and academic founders. For a biotech analyst, Petri is best understood as an enabling platform for biotech company creation rather than a drug developer with an internal pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Petri.